September 01, 2016
Amneal Pharmaceuticals LLC will be allowed to sell a generic version of Allergan PLC's Alzheimer's medication Namzaric in 2025 as part of a settlement announced Wednesday, likely ending litigation in Delaware federal court over the alleged infringement of a dozen patents.